The harm reduction program shall provide participants with:
A. sterile hypodermic syringes and needles in exchange for used hypodermic syringes, needles or other objects used to inject controlled substances or controlled substance analogs into the human body;
B. other objects used to prepare or consume controlled substances or controlled substance analogs;
C. supplies or devices used for testing controlled substances or controlled substance analogs for potentially dangerous adulterants;
D. supplies or devices approved by the department for distribution in accordance with rules established pursuant to Subsection E of Section 24-2C-4 NMSA 1978;
E. education on the prevention of:
(1) the transmission of the human immunodeficiency virus and hepatitis B and C; and
(2) drug overdose mortality and other negative health outcomes; and
F. referral to substance abuse treatment services.